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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
17.05.20 Prioritisation of 
ICU 
Treatments for 
Critically Ill 
Patients in a 
COVID-19 
Pandemic With 
Scarce 
Resources 
Anaesthesia 
Critical Care & 
Pain 
Medicine/ 
Journal Pre-
proof 
 Prioritising both critical care initiation 
and continuation is paramount to save 
the greatest number of lives. It 
enables to allocate scarce resources 
in priority to those with the highest 
probability of benefiting from them. 
 Prioritisation schemes and their 
criteria are adjusted to the level of 
resource scarcity 
  
19.05.20 Medical 
Doctors 
Awareness, 
Perception, 
and Attitude 
towards 
COVID-19 in 
Bangladesh: A 
Cross sectional 
study 
preprints from 
medRxiv (not 
peer-
reviewed) 
 Cross sectional, web-based study was 
conducted with the help of an online 
questionnaire and sent to doctors 
  
 Conclusion: The health authorities 
should take appropriate training 
measures to increase the awareness 
of the medical doctors along with 
providing sufficient amount of personal 
protective equipment for the medical 
doctors and supporting staff before 
deploying them in hospitals. 
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Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
19.05.20 Temporal and 
spatial 
characteristics 
of the spread of 
COVID-19 in 
Rio de Janeiro 
state and city 
preprints from 
medRxiv (not 
peer-
reviewed) 
 Study analyses temporal and spatial 
characteristics of the spread of 
COVID-19 in the municipalities of the 
state of Rio de Janeiro, based on 
open data published by the Health 
Departments of Governments of the 
State of RJ and the Municipality of 
Rio de Janeiro, from February 27 - 
April 27, 2020. 
 Results suggest that the initial stages 
of spreading the virus across the 
state occur exponentially, with 
specific regions with a higher 
concentration of rates of cases, 
deaths and recovered people. 
 Qualitative and quantitative results, 
point out that the regions with the 
highest income average per capita 
have higher rates of confirmed cases 
and recovered people, however, high 
lethality is found in places of low 
income per capita.  
  
19.05.20 COVID-19 
Epidemic 
Forecast in 
Different States 
of India using 
SIR Model 
preprints from 
medRxiv (not 
peer-
reviewed) 
 It is estimated that the epidemic 
curve flattening in India will start from 
the first week of July and epidemic 
may end in the third week of October 
with final epidemic size ~1,75,000. 
 The epidemic in Kerala is in final 
phase and is expected to end by first 
week of June.  
 Maharashtra is severely affected 
where the ending phase of epidemic 
may occur in the second week of 
September with epidemic size of 
~55,000. The model indicates that 
the fast growth of infection in Punjab 
is from 27th April 2020 to 2nd June 
2020, thereafter, curve flattening will 
start and the epidemic is expected to 
finished by the first week of July with 
the estimated number of ~3300 
3 
infected people. The epidemic size of 
COVID-19 outbreak in Delhi, West 
Bengal, Gujrat, Tamil Nadu and 
Odisha can reach as large as 
24,000, 18,000, 16,000, 13,000 and 
11,000, respectively, 
  
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
19.05.20 Assessment of 
service 
availability and 
Infection 
prevention 
measures in 
hospitals of 
Nepal during 
the transition 
phase of 
COVID-19 
case surge 
preprints from 
medRxiv (not 
peer-
reviewed) 
 Nepalese medical fraternity 
expressed concerns regarding 
public health strategies of 
government and hospital 
readiness in response to upgoing 
case surge.  
 Service availability and Infection 
prevention and control (IPC) 
status was assessed in 110 
hospitals situated across seven 
provinces via electronic survey 
sent out to the frontline clinicians 
24th March- 7th April 2020; one 
response per hospital was 
analyzed. 
 Findings alert the Nepalese and 
other governments to act early 
and proactively during health 
emergencies and not wait until 
the disease disrupts their health 
systems. 
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Comments, Editorials, Opinions, Blogs, News 
18.05.20 Better the drug you know: 
Commentary on “Daughton 2020, 
Natural experiment concept to 
accelerate the re-purposing of 
existing therapeutics for Covid-19” 
Global Epidemiology/ 
Commentary 
Alex Broadbent 
19.05.20 When does a major outbreak become 
a Public Health Emergency of 
International Concern? 
Lancet Infectious 
Diseases/ Comment 
David N 
Durrheim, 
Laurence O 
Gostin, 
Keymanthri 
Moodley 
May 
2020 
Water, climate change, and COVID-
19: prioritising those in water-stressed 
settings 
Lancet Planetary 
Health/ 
Correspondence 
Richard 
Armitage, 
Laura B 
Nellums 
May 
2020 
Shared sanitation and the spread of 
COVID-19: risks and next steps 
Lancet Planetary 
Health/ 
Correspondence 
Bethany A 
Caruso, 
Matthew C 
Freeman 
19.05.20 How environmental racism is fuelling 
the coronavirus pandemic 
Nature/ Comment Harriet A. 
Washington 
19.05.20 Tackle coronavirus in vulnerable 
communities 
Nature/ Editorial    
19.05.20 United Nations, World Health 
Organization Caution COVID-19 
Disruptions Could Foster Surge in 
Extra AIDS-Related Deaths  
JAMA Health Forum Joan 
Stephenson 
19.05.20 In the Face of the COVID-19 
Pandemic We Are Only as Strong as 
the Weakest of Us 
IPS/ opinion David Nabarro 
and Joe 
Colombano 
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20.05.20 Kenya: Youth Emerge as COVID-19 
Superspreaders 
All Africa news   
19.05.20 WHO countries agree 'equitable and 
timely access' to coronavirus vaccine, 
'comprehensive evaluation' of 
response 
UN news   
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence 
& policy 
maps 
Current 
research 
including trials 
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SARS-
CoV-2 Test 
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  Global 
COVID-19 
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Trial 
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EPPI 
Centre 
WHO 
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Clinical Trials 
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SARS-
CoV-2 
Diagnostic
s: 
performanc
e data 
  US NIH 
registered 
clinical 
trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
Europea
n CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
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COVID-19 
  Solidarity 
trial 
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19 
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  Sierra 
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 Oxford 
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Testing 
  COVID-
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Therapeuti
cs 
Accelerator 
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Our World 
in Data 
  Singapor
e 
 Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 
5050 
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ov 
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Africa 
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  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin 
of the 
WHO 
ICL MRC Centre for Global 
Infectious Disease Analysis  
Global 
Menstrual 
Collective  
  Disability 
and 
inclusion 
WHO Global 
research 
GeoPoll
: SSA 
Cambridg
e 
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y Press 
ODI SLH: 
Handwashi
ng in low 
resource 
settings 
  Coregrou
p IDDC 
COVID-19 
Solidarity 
Response 
Fund 
Global 
Health 
Network 
Africa 
Cell 
Press 
Johns Hopkins University 
 
  Ethics, 
health 
systems & 
COVID-19 
UN African 
Academ
y of 
Science
s 
Cochrane  Center for Global 
Development 
    Social 
Developme
nt Direct 
C19 blog 
series 
UN Women Africa 
Evidenc
e 
Network 
Elsevier CMMID Repository     
UNOCHA OCHA 
Souther
n and 
Eastern 
Africa 
COVID-
19 
Digest 
JAMA 
Network 
Norwegian Institute of Public 
Health 
    
UNHCR   The 
Lancet 
Oxford Centre for Evidence-
based Medicine 
    
UNICEF   medRxiv 
and 
 HEART     
8 
bioRxiv 
(Preprints
) 
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
Universit
y Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
      
World Bank   Science       
Our World in 
Data 
  Springer 
Nature 
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Narratives by 
David 
Nabarro 
  SSRN 
(Preprints
)  
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OpenStreetM
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Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
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COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
10 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
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